Literature DB >> 22538844

[Critical limb ischemia in systemic sclerosis].

M O Becker1, G Riemekasten.   

Abstract

Vascular complications are common in systemic sclerosis (SSc). Critical limb ischemia leading to gangrene or amputation occurs in more than 10% of these patients and hence is a common emergency. This report highlights the different pathogenetic mechanisms leading to critical ischemic events and provides guidance for the diagnosis and therapy. Apart from SSc-associated vasculopathy and peripheral arterial disease, thromboembolic events and rarely also vasculitis may cause critical limb ischemia. An interdisciplinary approach to the diagnosis and therapy of these lesions is mandatory. Therapy goals are the prevention of further ischemia and, if possible, revascularization as well as optimal pain management.

Entities:  

Mesh:

Year:  2012        PMID: 22538844     DOI: 10.1007/s00393-011-0914-3

Source DB:  PubMed          Journal:  Z Rheumatol        ISSN: 0340-1855            Impact factor:   1.372


  86 in total

1.  Efficacy of bosentan in digital ischemic ulcers.

Authors:  José A Todoli Parra; Manuel Miralles Hernández; Manuel A Arrébola López
Journal:  Ann Vasc Surg       Date:  2010-07       Impact factor: 1.466

2.  Targeting activated T cells: successful use of anti-CD25 monoclonal antibody basiliximab in a patient with systemic sclerosis.

Authors:  H U Scherer; G-R Burmester; G Riemekasten
Journal:  Ann Rheum Dis       Date:  2006-09       Impact factor: 19.103

3.  Effect of a nonselective endothelin antagonist on vascular remodeling in deoxycorticosterone acetate-salt hypertensive rats. Evidence for a role of endothelin in vascular hypertrophy.

Authors:  J S Li; R Larivière; E L Schiffrin
Journal:  Hypertension       Date:  1994-08       Impact factor: 10.190

4.  EULAR recommendations for the treatment of systemic sclerosis: a report from the EULAR Scleroderma Trials and Research group (EUSTAR).

Authors:  O Kowal-Bielecka; R Landewé; J Avouac; S Chwiesko; I Miniati; L Czirjak; P Clements; C Denton; D Farge; K Fligelstone; I Földvari; D E Furst; U Müller-Ladner; J Seibold; R M Silver; K Takehara; B Garay Toth; A Tyndall; G Valentini; F van den Hoogen; F Wigley; F Zulian; Marco Matucci-Cerinic
Journal:  Ann Rheum Dis       Date:  2009-01-15       Impact factor: 19.103

5.  Comparison of patients with and without digital ulcers in systemic sclerosis: detection of possible risk factors.

Authors:  C Sunderkötter; I Herrgott; C Brückner; P Moinzadeh; C Pfeiffer; J Gerss; N Hunzelmann; M Böhm; T Krieg; U Müller-Ladner; E Genth; E Schulze-Lohoff; M Meurer; I Melchers; G Riemekasten
Journal:  Br J Dermatol       Date:  2009-01-13       Impact factor: 9.302

6.  Digital ischemic loss in systemic sclerosis.

Authors:  Umaima Marvi; Lorinda Chung
Journal:  Int J Rheumatol       Date:  2010-08-24

7.  Associations with digital ulcers in a large cohort of systemic sclerosis: results from the Canadian Scleroderma Research Group registry.

Authors:  Sarit Khimdas; Sarah Harding; Ash Bonner; Brittany Zummer; Murray Baron; Janet Pope
Journal:  Arthritis Care Res (Hoboken)       Date:  2011-01       Impact factor: 4.794

8.  Long-term outcome of Raynaud's syndrome in a prospectively analyzed patient cohort.

Authors:  G J Landry; J M Edwards; R B McLafferty; L M Taylor; J M Porter
Journal:  J Vasc Surg       Date:  1996-01       Impact factor: 4.268

9.  Paraneoplastic digital thrombosis: a case report.

Authors:  G Albin; A C Lapeyre; R L Click; M J Callahan
Journal:  Angiology       Date:  1986-03       Impact factor: 3.619

10.  A score of risk factors associated with ischemic digital ulcers in patients affected by systemic sclerosis treated with iloprost.

Authors:  Paola Caramaschi; Nicola Martinelli; Alessandro Volpe; Sara Pieropan; Ilaria Tinazzi; Giuseppe Patuzzo; Helal Mahamid; Lisa Maria Bambara; Domenico Biasi
Journal:  Clin Rheumatol       Date:  2009-03-20       Impact factor: 2.980

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.